— Know what they know.
Not Investment Advice

HELX

Franklin Genomic Advancements ETF
1W: -1.1% 1M: +3.1% 3M: +6.5% YTD: +20.0% 1Y: +37.6% 3Y: +54.7% 5Y: -22.1%
$43.79
+0.26 (+0.60%)
 
Weekly Expected Move ±3.1%
$41 $42 $44 $45 $47
ETF CBOE · AUM $32.8M

Portfolio Health Summary

IS Overall Score
54.6
★★★★★
Altman Z-Score
12.67
Safe
Weight Coverage
99%
of portfolio analyzed
Holdings Matched
63
with fundamental data

InsiderStreet Scorecard

★★★★★ 54.6
Profitability
45.3
Balance Sheet
54.5
Earnings Quality
51.5
Growth
66.0
Value
36.0
Momentum
72.0
Safety
84.5

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
12.67
Safe Zone (>2.99)
Piotroski F-Score
5.5 / 9
Moderate
Beneish M-Score
-1.77
Possible Manipulator
Credit Score
—
Earnings Quality
51.5 / 100

Portfolio Valuation

P/E
32.38x
P/B
7.68x
P/S
13.36x
EV/EBITDA
22.48x
EV/Revenue
13.59x
P/FCF
39.78x
P/OCF
26.50x
PEG
1.38x
Earnings Yield
3.09%
FCF Yield
2.51%
OCF Yield
3.77%
Median P/E
7.98x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +37.4%
Net Income +35.8%
EPS +39.0%
FCF +33.0%
EBITDA +34.9%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +42.4%
Rev CAGR 5Y +31.5%
EPS CAGR 3Y +23.5%
EPS CAGR 5Y +16.0%
FCF CAGR 3Y +22.0%
FCF CAGR 5Y +24.1%
EBITDA CAGR 3Y +16.4%
EBITDA CAGR 5Y +14.3%
Payout Ratio
6.80%
Buyback Yield
0.86%
Dividend Yield
0.23%
Total Shareholder Return
-0.44%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1655 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$43.79
Median 1Y
$46.36
5th Pctile
$29.75
95th Pctile
$72.17
Ann. Volatility
27.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 32.38
Portfolio P/B 7.68
Portfolio P/S 13.36
EV/EBITDA 22.48
EV/Revenue 13.59
P/FCF 39.78
P/OCF 26.50
PEG 1.38
Earnings Yield 3.09%
FCF Yield 2.51%
OCF Yield 3.77%
Median P/E 7.98
Profitability & Returns (9)
MetricValue
Gross Margin 56.67%
Operating Margin 41.71%
Net Margin 40.80%
FCF Margin 33.34%
ROE 19.92%
ROA 12.82%
ROIC 19.82%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.18
Debt/Assets 0.11
Net Debt/EBITDA -0.26
Interest Coverage 69.96
Current Ratio 1.80
Quick Ratio 1.05
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 37.35%
Net Income Growth 35.75%
EPS Growth 38.98%
FCF Growth 32.99%
EBITDA Growth 34.95%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 42.39%
Revenue CAGR 5Y 31.51%
Revenue CAGR 10Y —
EPS CAGR 3Y 23.46%
EPS CAGR 5Y 15.95%
EPS CAGR 10Y —
FCF CAGR 3Y 21.97%
FCF CAGR 5Y 24.09%
FCF CAGR 10Y —
EBITDA CAGR 3Y 16.41%
EBITDA CAGR 5Y 14.31%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 24.03%
Net Income CAGR 5Y 16.07%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 54.6
IS Profitability 45.3
IS Balance Sheet 54.5
IS Earnings Quality 51.5
IS Growth 66.0
IS Value 36.0
IS Momentum 72.0
IS Safety 84.5
IS Quality 58.4
Altman Z-Score 12.67
Piotroski F-Score 5.53
Beneish M-Score -1.77
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.23%
Payout Ratio 6.80%
Buyback Yield 0.86%
Total Shareholder Return -0.44%
Growth Stability (4)
MetricValue
Revenue Stability 0.763
Earnings Stability 0.424
Earnings Persistence 0.688
Margin Stability 0.834
Medians (3)
MetricValue
Median P/E 7.98
Median P/B 6.45
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 98.85%
Holdings Matched 63
Total Holdings 68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms